Larvol Delta - Phase-2B-GI-safety-results-for-ATB346-published-in-British-Journal-of-Pharmacology

hydrogen sulphide-releasing derivative of naproxen (ATB-346) - Antibe

https://www.businesswire.com/news/home/20190416005169/en/Phase-2B-GI-Safety-Results-ATB-346-Published

Apr 16, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next